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CD4+ T-cellTetherin is a host cell restriction factor that acts against HIV-1 and other enveloped viruses. The antiviral
activity of tetherin is antagonized by the HIV-1 protein Vpu, that downregulates tetherin from the cell surface.
Here, we report the speciﬁc detection of cell surface tetherin levels in primary activated CD4+ T-cells and in
CD4+ T-cell lines. Differences were observed regarding tetherin cell surface expression, Vpu-mediated
tetherin downmodulation and promotion of virus release. However, Vpu expression in all T-cell lines resulted
in a 2-fold increase in numbers of infected cells after three days. This implies a Vpu-mediated effect in ongoing
infection and possibly in cell-to-cell viral spread that is independent of the extent of Vpu-mediated tetherin
cell surface downmodulation. Endogenous cell surface tetherin levels in T-cell lines were also down-
modulated following infection with Vpu-deleted virus, suggesting an additional Vpu-independent
mechanism of tetherin cell surface downmodulation following HIV-1 infection in T-cell lines.enter, Lady Davis Institute for
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Tetherin (BST-2/CD317/HM1.24) is a host cell restriction factor
that contributes to cellular defense against infection by HIV-1 and
other enveloped viruses; tetherin-mediated restriction is interferon
responsive (Jouvenet et al., 2009; Neil et al., 2008; Van Damme et al.,
2008). In HIV-1 infections, the viral protein Vpu antagonizes tetherin-
mediated restriction and promotes virus release (Neil et al., 2008; Van
Damme et al., 2008). The antiviral action of tetherin is due to its
presence in the membrane of budding viral particles, tethering
nascent viral particles to the cell surface and to each other (Kupzig
et al., 2003; Neil et al., 2008; Perez-Caballero et al., 2009; Van Damme
et al., 2008). At the cell surface, tetherin localizes to lipid rafts
(Gofﬁnet et al., 2009; Kupzig et al., 2003; Rollason et al., 2009, 2007),
which, during the HIV-1 life cycle are the focus of viral assembly,
budding, as well as entry; lipid rafts are involved in both cell-free virus
spread and direct cell-to-cell spread (reviewed in (Waheed and Freed,
2009)). Direct cell-to-cell spread is reported to increase the efﬁciencyof HIV-1 transmission by 100–18,000 times compared to cell-free
spread and is considered to be the predominantmode of HIV-1 spread
in T-cell lines and in secondary lymphoid tissue (Chen et al., 2007;
Dimitrov et al., 1993; Gummuluru et al., 2000; Hübner et al., 2009;
Sourisseau et al., 2007) (reviewed in (Mothes et al., 2010; Sattentau,
2008)). In addition to restricting virus release and subsequently cell-
free viral spread, we and others have shown that tetherin also inhibits
direct cell-to-cell transmission in T-cells (Casartelli et al., 2010; Kuhl
et al., 2010b). Others have reported that HIV-1 might overcome
tetherin-mediated restriction of direct cell-to-cell viral spread (Jolly et
al., 2010).
The capacity of tetherin to restrict virus release is commonly
attributed to its cell surface expression. Vpu activity in counteracting
tetherin-mediated restriction is believed to result from Vpu-mediated
tetherin cell surface down-regulation, which either results from
tetherin degradation or from its sequestration in intracellular
compartments (Dubé et al., 2010; Dube et al., 2009; Gofﬁnet et al.,
2009; Iwabu et al., 2009; Mangeat et al., 2009; Perez-Caballero et al.,
2009; Van Damme et al., 2008). Most of these data were obtained
using the HeLa epithelial cell line, which expresses high endogenous
levels of tetherin or with the 293T human embryonic kidney cell line,
which naturally lacks tetherin expression and must be transfected
with tetherin-expressing plasmids.
The speciﬁc detection of tetherin expression at the cell surface has
been reported for only a few cell lines (HeLa, MT-4, COS-7) and for
primary B-cells, plasmacytoid dendritic cells (pDCs) and monocyte
derived macrophages (MDMs) (Blasius et al., 2006; Mitchell et al.,
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Damme et al., 2008; Vidal-Laliena et al., 2005). Interferon-α (IFNα)
increased cell surface expression in these cells and also induced
detectable cell surface expression in 293T cells (Van Damme et al.,
2008). In peripheral blood mononuclear cells (PBMCs), total cellular
tetherin expression had previously only been shown after IFNα-
treatment by Western blot of cell lysates (Miyagi et al., 2009).
It was recently reported that endogenous tetherin is differentially
modiﬁed at the post-translational level compared to tetherin that is
derived from an exogenous source (Andrew et al., 2010). Cell-line
speciﬁc differences have been reported for expression patterns of
other host cell restriction factors, such as APOBEC3G, which also
confers resistance to HIV-1 infections andwhich is antagonized by the
viral accessory protein Vif (reviewed in (Henriet et al., 2009;
Niewiadomska and Yu, 2009)). APOBEC3G is expressed and restricts
viral replication in CEM-CCRF cells but not in a derivative cell line
CEM-SS (Foley et al., 1965; Sheehy et al., 2002).
Few studies have investigated the relationship between cell
surface tetherin expression and virus release in infected T-cell lines
(Miyagi et al., 2009; Rong et al., 2009; Sato et al., 2009). While virus
releasemight be attributed to expression levels of cell surface tetherin
in MT-4 (Harada et al., 1985; Sato et al., 2009) and stably transduced
Sup-T1 cells (Rong et al., 2009), other work that used the H9 T-cell
line and the CEMx174 T/B-cell fusion cell line reported tetherin-
mediated restriction that was independent of tetherin cell surface
levels, suggesting the possibility of cell-type speciﬁc differences in the
effect of tetherin on virus release (Miyagi et al., 2009). To address this,
we determined tetherin cell surface expression in relation to virus
release and infection rates. Here, we report speciﬁc detection of cell
surface tetherin expression in primary activated CD4+ T-cells and in
multiple T-cell lines. Strong differences in regard to tetherin cell
surface expression, Vpu-mediated tetherin downmodulation, and
promotion of virus release were observed among them.We show that
the inﬂuence of Vpu on multiple-round infections was equivalent in
all T-cell lines, and that twice as many cells were infected at 72 h post
infection (p.i.) in the case of vpu-containing compared to Δvpu
infections. This implies a tetherin-mediated effect on cell-to-cell
spread that is not directly related to its cell surface expression. In
addition, we report a Vpu-independent downregulation of endoge-
nous tetherin following infection of CD4+ T-cell lines.Results
Variation of tetherin cell surface expression in T-cell lines
We ﬁrst assessed the cell surface expression of endogenous
tetherin by ﬂow cytometry in CEM-CCRF, CEM-SS, and H9 cells, in
addition to Sup-T1 cells stably transduced with human tetherin (Kuhl
et al., 2010b; Rong et al., 2009). We were able to speciﬁcally detect
and assess cell surface expression of tetherin in all of these cell lines
(Fig. 1A). Cell surface expression of tetherin varied between the cell
lines; relative mean expression levels were 9.1 in H9 cells, 23.4 in
CEM-CCRF cells and 44.5 in CEM-SS cells. In the case of the tetherin-
inducible Sup-T1 cell line, we employed a doxycycline titration
method to speciﬁcally induce cell surface tetherin levels that resemble
levels detected on T-cell lines (Figs. 1A and B). Induction with 5 ng/ml
doxycycline resulted in a relative mean cell surface expression of
tetherin of 8.3, which was similar to that obtained in H9 cells.
We also assessed cell size and cell granularity/complexity by ﬂow
cytometric analysis of forward scatter (FSC) and side scatter (SSC),
respectively. Side scatter patterns differed between cell types due to
differences in cell granule content which in combination with FSC is a
commonly used characteristic for identiﬁcation of cell populations. All
cell lines tested here were of similar size (FSC) and granularity/
complexity (Figs. 1C and D).Cell line speciﬁc differences of vpu-mediated tetherin downmodulation
Next, we assessed the capacity of Vpu to downregulate cell surface
expression of tetherin following HIV-1 infection in the various cell lines.
Cells were infected to a level of ~10%, as assessed by ﬂow cytometric
detection of eGFP expression at 48 h p.i., with single-round infections,
i.e. env-deleted, wt (vpu-positive), or Δvpu (vpu-deleted) virus,
pseudotyped for entry with the Vesicular stomatitis virus protein G
(VSV-G) envelope. Tetherin cell surface expression in infected (eGFP
positive) and uninfected (eGFP negative) cells was determined by ﬂow
cytometry. In the stably transduced Sup-T1 cell line infected with wt
virus, tetherin cell surface levels were signiﬁcantly downregulated
compared to uninfected controls (~40%). Uninfected H9 cells showed
similar tetherin cell surface expression as did uninfected Sup-T1 cells
induced with 5 ng/ml doxycycline (Figs. 2A and B). However, infection
of H9 cells with wt virus resulted in only a modest tetherin down-
regulation (~27%) compared to uninfected cells (Fig. 2A). CEM-SS cells
exhibited signiﬁcantly higher tetherin cell surface levels than did the
parental CEM-CCRF cell line (Figs. 2C and D). In both these cell lines, cell
surface tetherin was downregulated in wt infection but to different
extents (CEM-SS: ~78%; CEM-CCRF: ~45%).
Vpu-independent tetherin modulation
In CEM-SS cells, cell surface tetherin was also downregulated after
infection by Δvpu virus, compared to uninfected controls (~47%)
(Fig. 2D); similar trends were observed with CEM-CCRF (~33%) and
H9 cells (~13%) (Figs. 2A and C). This effect was not observed in the
transduced Sup-T1 cell line (induced with 5 ng/ml doxycycline); such
cells, when infected with Δvpu virus, showed a slight, but statistically
insigniﬁcant upregulation of tetherin (~15%) (Fig. 2B).
Cell line speciﬁc effect of Vpu-mediated tetherin modulation on virus
release
To assess the effect of Vpu on virus release we infected the cell lines
with equal amounts of wt or Δvpu virus, based on CA p24 levels, and
measured virus release into the supernatant at 24, 48 and 72 h p.i. using
a quantitative reverse transcription-based assay (Fig. 3). Virus release at
baseline (24 h p.i.) was similar in all infections. Starting at 48 h p.i. Vpu
mediated increased levels of virus release in all cell lines, though the
effect differed among them. At 72 h p.i., the extent of the Vpu effect on
virus release (comparingwt and Δvpu) ranged from ~60% in H9 cells to
~550% in CEM-SS cells (CEM-CCRF: ~170%; induced Sup-T1: ~300%)
(Fig. 3). In order to compare the direct effect of Vpu on tetherin cell
surface downmodulation and virus release, we normalized the Vpu-
mediated increase of virus release to the extent of Vpu-mediated
tetherin cell surface downregulation (Table 1). A greater ratio implies a
stronger correlation of virus release and changes in tetherin cell surface
expression. The similarity of the ratios between CEM-CCRF cells (10.2)
and derivative CEM-SS cells (10.5) shows that tetherin-mediated
restriction of virus release was strongly affected by tetherin cell surface
expression levels in both instances. H9 cells showed a low ratio (3.5),
indicating a lower correlation between tetherin-mediated restriction of
virus release and cell surface expression, while inducible Sup-T1 cells
showed an intermediate level of correlation (6.1).
Similar inﬂuence of Vpu in ongoing infection
Using ﬂow cytometry detection of virus-derived eGFP expression at
72 h p.i., we assessed cell line susceptibility to wt virus. Infections with
equal amounts ofwt virus, based on CA p24 levels, resulted in infection
rates ranging from ~1% in H9 cells to ~40% in inducible Sup-T1 cells
(CEM-SS: ~3%; CEM-CCRF: ~20%) (Fig. 4). The presence of Vpu
(comparing wt and Δvpu virus) increased infection rates at 72 h p.i. to
similar levels in all cell lines, ranging from a 107% increase in CEM-CCRF
Fig. 1. Tetherin cell surface levels in T-Cell lines. Representative overlay of tetherin cell surface expression levels (A and B), cell size (C) and cell granularity (D) Cell surface tetherin
levels assessed by ﬂow cytometry detection of PerCP-levels in (A) H9 (blue), CEM-CCRF (rose), CEM-SS (turquoise) and Sup-T1 cells, induced with 5 ng/ml doxycycline (green), and
(B) in Sup-T1 cells induced with 5 ng/ml (green), 20 ng/ml (turquoise) and 100 ng/ml (rose) doxycycline, and in uninduced Sup-T1 cells (blue); (A and B) Controls are unstained,
induced Sup-T1 cells (100 ng/ml doxycycline, yellow) and induced Sup-T1 cells (100 ng/ml doxycycline, red) stained with the secondary antibody only. Cell size (C) and granularity
(D) of H9 (blue), CEM-CCRF (rose), CEM-SS (turquoise) and Sup-T1 cells, induced with 5 ng/ml doxycycline (green), were analyzed according to ﬂow cytometry detection of forward
scatter (FSC) and side scatter (SSC), respectively.
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126%)(Fig. 4).
Vpu and tetherin expression in infected primary CD4+ T-cells
In order to account for the importance of the described role of Vpu/
tetherin in T-cell lines, we next assessed this interrelationship in
primary activated CD4+ T-cells. In brief, PBMCs were negatively
selected for CD4+ T-cells and activated using phytohemagglutinin A
(PHA) and interleukin 2 (IL-2). We were able to speciﬁcally detect
endogenous tetherin cell surface expression in activated primary
CD4+ T-cells (Fig. 5A). Tetherin cell surface expression was elevated
by 55% upon induction with 50 U/ml IFNα compared to untreated
controls withmean expression levels rising from 19 (absence of IFNα)
to 29.4 (50 U/ml IFNα) (Fig. 5B). Higher concentrations of IFNα did
not result in further signiﬁcant elevation of tetherin cell surface levels
(250 U/ml IFN: 29.3; 500 U/ml IFN: 30.7) (Fig. 5B).
To assess the effect of Vpu on tetherin downmodulation and on
ongoing infections in primary CD4+ T-cells, cells were infected with
equal amounts of wt and Δvpu virus, and cell surface tetherin levelswere measured using ﬂow cytometry. Cells were also treated with
IFNα (250 U/ml) at 24 h p.i., a time point which allowed integration to
occur. In the absence of IFNα, Vpu downmodulated tetherin cell
surface levels in infected (eGFP positive) cells by 27% compared to the
uninfected (eGFP negative) population (Fig. 5C); in IFNα-treated
populations, wt infected cells showed similarly reduced tetherin
expression levels (25% lower than in uninfected cells) (Fig. 5D).
Infections with Δvpu virus in IFN-treated and untreated cell popula-
tions resulted in a slight, but statistically insigniﬁcant, upregulation of
tetherin cell surface levels compared to uninfected (eGFP negative)
cell populations (untreated: 5%; IFN-treated (250 U/ml): 15%)
(Figs. 5C and D). As with our analysis of T-cell lines, we normalized
Vpu-mediated virus release to the ability of Vpu to downmodulate
tetherin cell surface levels. IFNα-treated and untreated primary CD4+
T-cells showed similar ratios of 1.8 (no IFNα) and 2 (250 U/ml IFNα)
and therefore, compared to T-cell lines, might have lower tetherin cell
surface activity on virus release (Table 1).
Vpu promoted virus release in both IFNα-treated and untreated
activated cells. In untreated populations, Vpu promoted virus release
by ~45%, comparing wt to Δvpu infections, as assessed by reverse
Fig. 2. Tetherin cell surface modulation in infected T-cell lines. Geometric means of cell surface expression of tetherin in T-cell lines H9 (A), Sup-T1 (B; induced by 5 ng/ml
doxycycline), CEM-CCRF (C) and CEM-SS (D). Cells were infected at a rate of 10% with VSV-G pseudotyped wt and Δvpu BR-NL43-IRES-eGFP. At 48 h p.i., cells were gated into
uninfected and infected populations based on their virus-derived eGFP expression proﬁle, and cell surface levels of tetherin were assessed. Data are derived from aminimum of three
independent experiments. Error bars represent the SEM. Statistical signiﬁcance between uninfected cells, cells infected with wt or Δvpu virus, as assessed by One-Way ANOVA,
coupled with Bonferroni's post-test, is indicated at the top of the graph.
356 B.D. Kuhl et al. / Virology 417 (2011) 353–361transcriptase activity in culture supernatants at 72 h p.i. (Fig. 5E). This
Vpu-mediated effect was elevated to ~70% in IFNα-treated popula-
tions. Treatment with IFNα decreased virus release by ~27% and ~50%
in wt and Δvpu infections, respectively.Fig. 3. Varying impact of Vpu on virus release. The T-cell lines H9 (A), Sup-T1 (induced, B),
(600 ng p24 per 106 cells) by spinoculation. Synchronized infections were also carried out. V
from three independent experiments are presented; error bars represent SEM. Statistical anIFN-α treatment reduced the susceptibility of CD4+ T-cell
populations to productive infection, as assessed by ﬂow cytometry
detection of eGFP at 72 h p.i.; infection rates were reduced from ~7%
to ~2% (~70% reduction) in wt infections and from ~1.6% to ~0.4%CEM-CCRF (C) and CEM-SS (D) were infected with equal amounts of wt or Δvpu virus
irus release was assessed at 24 h, 48 h and 72 h p.i. by reverse transcriptase assay. Data
alysis was assessed using Student's t-test.
Table 1
Cell line-speciﬁc correlations of Vpu-mediated tetherin cell surface downmodulation and virus release, based on comparison of wt infection to Δvpu infection.
Cell type Δ Cell surface tetherin
(ΔCST)
Δ Virus release
(ΔVR)
Tetherin cell surface activity
(ΔVR/ΔCST)
H9 17% 60% 3.5
Sup-T1
(5 ng/ml dox)
49% 300% 6.12
CEM-CCRF 16% 168% 10.5
CEM-SS 54% 553% 10.2
Primary CD4+
(no IFNα)
26% 45% 1.8
Primary CD4+
(250 U/ml IFNα)
35% 70% 2
357B.D. Kuhl et al. / Virology 417 (2011) 353–361(~75% reduction) in Δvpu infected populations (Fig. 5F). Vpu
mediated an increase in infection rate by ~400% in IFNα-treated
cells and ~330% in untreated populations, based on equal levels of
CAp24 input.Discussion
Here, we have investigated the roles of tetherin-mediated
restriction and Vpu-mediated antagonism in the context of ongoing
infection in primary CD4+ T-cells and in the CD4+ T-cell lines H9,
CEM-CCRF, CEM-SS and the tetherin-inducible Sup-T1 cell line. CEM-
SS is a direct derivative cell line of CEM-CCRF; however, these two cell
lines show different susceptibility to HIV-1 infection and were shown
to differ in their expression proﬁle of host cell restriction factor
APOBEC3G (Sheehy et al., 2002). It is not known whether these cell
lines also exhibit differences in regard to tetherin. Additionally, CEM-
CCRF cells were used for development of the T-cell/B-cell fusion cell
line CEMx174 (Foley et al., 1965; Salter et al., 1985); tetherin in
CEMx174 and H9 cells was recently proposed to restrict virus release
independent of its cell surface expression (Miyagi et al., 2009).
Induced tetherin expression of stably transduced Sup-T1 cells, wasFig. 4. Vpu promotes viral spread in various T-cell lines at similar levels. The T-cell lines H9 (
equal amounts of wt or Δvpu BR-NL43-IRES-eGFP virus (600 ng p24 per 106 cells) by spino
expression. Data are derived from three independent experiments; error bars represent SErecently shown to restrict direct cell-to-cell spread of HIV-1 in the
absence of Vpu (Kuhl et al., 2010b).
In our studies, endogenous tetherin cell surface expression in all T-
cell lines differed, with endogenous cell surface tetherin in Sup-T1 cells
being at the limit of detection by ﬂow cytometry. Expression levels
amongH9, CEM-CCRF and CEM-SS cells varied ~4-fold (Fig. 1A). Using a
doxycycline titration method in tetherin-inducible Sup-T1 cells, we
were able to mimic these endogenous cell surface levels (Fig. 1B). The
similar size and granularity/complexity observed among the cells
conﬁrms their overall similarity and implies that differences in tetherin
detection are due to genuine differences in tetherin expression levels at
the cell surface and not due to differences in size and/or cell complexity
between the cell lines tested here (Figs. 1C and D).
We have also been able to speciﬁcally detect tetherin cell surface
expression in primary activated CD4+ T-cells by ﬂow cytometry
(Fig. 5A). Mean cell surface tetherin levels of activated CD4+ T-cells
were upregulated by 50–60% by treatment with IFNα. This effect
seemed to be saturable (Figs. 5A and B), as previously observed in
MDMs (Miyagi et al., 2009). To our knowledge this is the ﬁrst report of
speciﬁc detection and quantiﬁcation of tetherin cell surface expres-
sion in primary CD4+ T-cells. A previous study failed to speciﬁcally
detect cell surface tetherin expression in activated (CD3/CD28) and/orA), CEM-CCRF (C), CEM-SS (D) and the induced cell line Sup-T1 (B) were infected with
culation. Infection rates were determined at 72 h p.i. by assessing virus-derived eGFP
M.
Fig. 5. Relationship between tetherin and Vpu in primary CD4+ T-cells. (A and B) Representative overlay (A) and quantiﬁcation of geometric means (B) of tetherin cell surface
expression levels. Cell surface tetherin levels assessed by ﬂow cytometry detection of PerCP-levels in PHA/IL-2 activated CD4+ T-cells (turquoise) and activated cells treated with
50 U/ml (purple), 250 U/ml (green) and 500 U/ml (blue) IFNα2b; (A) Controls are IFN-treated (500 U/ml IFNα2b) cells, unstained (yellow) or stained with the secondary antibody
only (red). (C–F) Primary CD4+ T-cells were infected with equal amounts of wt or Δvpu BR-NL43-IRES-eGFP virus (600 ng p24 per 106 cells) by spinoculation. At 72 h p.i. ﬂow
cytometry was utilized to assess infection rates by detection of virus derived eGFP expression (F) and tetherin cell surface expression in infected (eGFP positive) and uninfected
(eGFP negative) populations via Per-CP detection (E). (D–F) Primary CD4+ T-cells were stimulated with 250 U/ml IFNα2b at 24 h p.i. (B–F). Data are derived from a minimum of
three independent experiments. Error bars represent the SEM. Statistical signiﬁcance of differences, as assessed by One-Way ANOVA, coupled with Bonferroni's post-test, is indicated
at the top of the graph.
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of levels of cellular tetherin using Western blot techniques on cell
lysates has been reported (Miyagi et al., 2009). The speciﬁc detection
of tetherin cell surface expression, and its elevation by IFNα, as
detected by ﬂow cytometry in activated CD4+ T-cells that were
separated from PBMCs, suggests that cell surface expression in other
types of PBMC populations might occur but be below the level of
detection of common assays. IFNα might also induce overall cellular
tetherin levels in PBMCs, as tetherin was detected in Western blots of
IFN-treated PBMCs (Miyagi et al., 2009).
Furthermore, the cell surface presence of tetherin in the absence of
IFNα supports the notion that tetherin be characterized as an intrinsicrestriction factor in activated primary CD4+ T-cells that is elevated
upon IFNα induction. It is unknown whether activation of T-cells
induces tetherin expression.
Tetherin cell surface expression was downregulated following wt
infection in all cell lines and in primaryCD4+T-cells, though cell speciﬁc
differences of up to 4-fold were observed. The capacity of Vpu to
promote tetherin cell surface expression in primary CD4+ T-cells was
similar in IFNα-treated and untreated populations and was in the
middle of the range of Vpu activity in T-cell lines (Figs. 2 and 5C and D).
Interestingly, cell surface expression of tetherin was downregulated
following infection with Δvpu virus in H9, CEM-CCRF and CEM-SS cells
(Fig. 2). This effect was neither observed in the transduced Sup-T1 cell
359B.D. Kuhl et al. / Virology 417 (2011) 353–361line (induced with 5 ng/ml doxycycline (Fig. 2B) or 100 ng/ml
doxycycline (Kuhl et al., 2010b)) or in primary CD4+ T-cells (Figs. 5C
and D), nor in HeLa or transfected 293T cells (Perez-Caballero et al.,
2009; Van Damme et al., 2008), and might therefore be limited to
endogenous tetherin in T-cell lines. Vpu-independent partial down-
regulation of endogenous tetherin in T-cell lines might be mediated by
direct antagonismof tetherin via another viral protein or be due tomore
systemic effects of viral infection. As HIV-1 viral proteins, other than
Vpu, have not been shown to interact with tetherin, a more systemic
effect of viral infection seems likely. This effect might regulate tetherin
expression at the transcriptional or post-transcriptional level.
HIV-1 was recently proposed to disrupt important signaling and
transcription pathways of the immune system (Doehle et al., 2009;
Mogensen et al., 2010). DNA constructs for expression of exogenous
tetherin employ viral promoters for transcriptional regulation (e.g. CMV
promoter), which differ from the promoter region responsible for
transcription of the endogenous tetherin gene (Ohtomo et al., 1999).
Systemic regulation at the transcription levelmight therefore only affect
endogenous tetherin expression. A recent report on the differential
processing of endogenous and exogenous tetherin suggests a systemic
effect at a post-translational level (Andrew et al., 2010). In Kaposi's
sarcoma-associated herpes virus (KSHV) infection, tetherin is proposed
to be antagonized only at the post-translational level by viral ubiquitin
ligase K5 (Mansouri et al., 2009). The slight, but statistically insigniﬁcant
upregulation of tetherin in induced Sup-T1 cells (Fig. 2B) and in primary
CD4+ T-cells (Figs. 5C and D) has been previously described (Kuhl et al.,
2010b) and was also observed in CEMx174 T/B-cells (Andrew et al.,
2010).
We and others have previously shown that wt and Δvpu virus are
equally infectious in initial cell-free infections and that tetherin and
Vpu do not affect the kinetics of the initial round of HIV-1 infection
(up to 48 h p.i.) (Kuhl et al., 2010b; Miyagi et al., 2009; Sato et al.,
2009; Vendrame et al., 2009). The cell lines tested here showed
differential susceptibility towards HIV-1 infection (Fig. 4). As
expected, virus release was inﬂuenced by differences in infection
rates; however, virus release was increased in all cell lines by the
presence of Vpu (comparing wt and Δvpu virus). The Vpu-mediated
effect showed cell line speciﬁc variability of up to 10-fold (Fig. 3,
Table 1). In primary CD4+ T-cells, Vpu also promoted virus release, an
effect that was increased in the IFNα-treated population; IFNα
decreased virus release more strongly in Δvpu infected populations
than in wt infected populations (Fig. 5E, Table 1). Due to the systemic
induction of antiviral interferon-stimulated genes (ISGs) (reviewed in
Sadler and Williams, 2008), a systemic reduction of virus release (wt
and Δvpu virus) is not surprising. However, as tetherin is IFNα-
inducible and is antagonized by Vpu in HIV-1 infections (Figs. 5A and
B, (Neil et al., 2008; Van Damme et al., 2008)), it seems reasonable to
argue that the pronounced effect of Vpu on virus release in the IFNα-
treated population, when compared to untreated populations, is due
to Vpu-mediated tetherin antagonism.
The Vpu-independent effect of cell surface tetherin downmodula-
tion following HIV-1 infection in T-cell lines (Fig. 2), leads to the
question whether the Vpu-mediated increase in virus release is directly
related to its tetherin cell surfacedownmodulation activity, as suggested
previously (Perez-Caballero et al., 2009; Van Damme et al., 2008).
Normalization of the Vpu-mediated increase of virus release by the
extent of Vpu-mediated tetherin cell surface downregulation allows
such comparison (Table 1). CEM-CCRF cells and their derivative CEM-SS
cells showed equally strong correlations of Vpu-mediated tetherin
downmodulation and virus release. This similarity also implies that,
despite their differences in cell surface expression, tetherin exerts
antiviral function in both CEM-CCRF and CEM-SS cells in a similar
manner, in contrast to observed differences in regard to APOBEC3G
expression (Sheehy et al., 2002). The strong correlation of virus release
andmodulation of cell surface tetherin levels in CEM-CCRF and CEM-SS
cells indicates that cell surface independent tetherin activity in T/B-cellCEMx174 fusion cells might be derived from the B-cell fusion partner
rather than from CEM-CCRF cells (Miyagi et al., 2009). The low
dependency of virus release on Vpu-mediated tetherin downmodula-
tion inH9cells is supportive of previouswork that suggestedanantiviral
activity of tetherin independent of its cell surface expression (Miyagi et
al., 2009). The low ratios in primary CD4+ T-cells further support the
existence of additional, cell surface independent, tetherin-mediated
antiviral activities. The intermediate correlation of induced Sup-T1 cells
substantiates the use of inducible cell lines as a research tool in regard to
tetherin-mediated effects (Kuhl et al., 2010a, 2010b; Rong et al., 2009).
Although there appears to be an inverse correlation between cell
surface tetherin and virus release, the effect of Vpu on viral spread at
72 h p.i. was found to be not directly comparable to the extent of Vpu-
mediated cell surface downregulation in T-cell lines. For example, Vpu
mediates a 2.1–2.3-fold increase of viral spread in all T-cell lines
examined (Fig. 4). We have previously shown that initial infection (up
to 48 h p.i.) is not affected by Vpu or tetherin (Kuhl et al., 2010b), after
which direct cell-to-cell transmission is predominant in T-cell cultures
(Chen et al., 2007; Gummuluru et al., 2000; Kuhl et al., 2010b;
Sourisseau et al., 2007). Therefore, the Vpu-mediated increase in viral
spread is likely to beaffectedpredominantly byVpu-mediatedeffects on
direct cell-to-cell transmission. In the context of cell-to-cell spread, Vpu
might impose a ﬁtness cost to the virus in the absence of tetherin;
however, in the presence of tetherin, Vpu mediates an increase in viral
spread through its tetherin-antagonizing activity (Kuhl et al., 2010b).
Thus, in the context of cell-to-cell transmission of HIV-1 in T-cells,
neither tetherin-mediated restriction nor Vpu-mediated antagonism
appears to be directly related to particular tetherin cell surface
expression levels. This provides further support for tetherin-mediated
restriction of cell-to-cell spread (Casartelli et al., 2010; Kuhl et al.,
2010b). We have previously reported a ~2-fold Vpu-mediated increase
of cell-to-cell spread in Sup-T1 cells induced to ~10-fold higher tetherin
cell surface expression (induced by 100 ng/ml doxycycline, Fig. 1B)
(Kuhl et al., 2010b) andothers reported similar effects of Vpu/tetherin in
various cell types, i.e. IFN-treated T-cell cultures and primary T-
lymphocytes, as well as 293T cells transfected with tetherin (Casartelli
et al., 2010; Vendrame et al., 2009).
In primary CD4+ T-cells, Vpu mediated an ~3 fold increase of
infection rates when comparing wt and Δvpu infected populations
(Fig. 5F). As with virus release, the effect was pronounced (~4 fold) in
IFNα-treated populations and might be attributable to Vpu-mediated
tetherin antagonism. Interferon-α treatment reduced infection rates
more than virus release, which indicates a restriction of ongoing
infections, with IFNα-mediated restriction acting at both late and
early infection stages in the viral life cycle (Vendrame et al., 2009).
Here, we report T-cell line differences in the relationship between
tetherin cell surface levels and virus release. Further, Vpu antagonismof
tetherin-mediated restriction in ongoing infection in T-cell lines is
independent of the level of tetherin cell surface downmodulation. These
results, combined with reports of source-dependent tetherin modiﬁca-
tions (Andrew et al., 2010) and cell type speciﬁc functions unrelated to
antiviral function (Cao et al., 2009; Rollason et al., 2009), suggest that
single round infection experiments in cells other than T-cells (HeLa or
293T) might not always be representative of tetherin-mediated
restriction/function in HIV-1 infections. To our knowledge, this is the
ﬁrst report of speciﬁcdetectionof tetherin cell surfaceexpressionand its
Vpu-mediated downmodulation in primary activated CD4+ T-cells.
Material and methods
Cell lines
H9, CEM-CCRF and CEM-SS cells were maintained in RPMI-1640
culture medium (Gibco) supplemented with 10% FBS. Transduced
Sup-T1 cells were maintained in RPMI-1640 supplemented with 10%
tetracycline-free bovine serum albumin (BSA), 2 μg/ml puromycin
360 B.D. Kuhl et al. / Virology 417 (2011) 353–361(Sigma), and 1 mg/ml G418 (Sigma). Tetherin expression in Sup-T1
cells was induced using doxycycline at concentrations of 100, 20 and
5 ng/ml (Sigma). CEM-CCRF cells were obtained from American Type
Culture Collection (ATCC) (Foley et al., 1965); H9 and CEM-SS cells
were obtained from the NIH AIDS Research and Reference Reagent
Program (Mann et al., 1989; Nara and Fischinger, 1988); Sup-T1 cells
stably transduced with the human tetherin gene were previously
described (Rong et al., 2009).
Primary CD4+ T-cells
Primary CD4+ T-cells were derived from peripheral mononuclear
cells (PBMCs). First, PBMCs were isolated from whole blood of pooled
donors by the Ficoll–Hypaque method. CD4+ T-cells were then
separated by negative selection using an Untouched Human CD4 T
Cells kit (Invitrogen). Cells were cultured in RPMI-1640 culture
medium (Gibco) supplemented with 10% FBS and 20 U/ml human
interleukin-2 (IL-2), and stimulated with 10 μg/ml phytohemagglu-
tinin A (PHA) for 72 h. For IFNα-treatment of activated cells, culture
medium was supplemented with 50 U/ml, 250 U/ml or 500 U/ml
Interferon-α-2b (Invitrogen) (Rong et al., 2009).
Viruses
Site-directed mutagenesis, using the QuickChange XLII Site-Directed
Mutagenesis Kit (Stratagene), was used to introduce nucleotide changes
into the coding regions of vpu and/or env, resulting in two stop codons at
thebeginning of Vpu and/or Env coding regions of the viral clonepBR43-
IRES-eGFP (NIH AIDS Research and Reference Reagent Program),
expressing enhanced green ﬂuorescent protein (eGFP) from an internal
ribosomal entry site downstreamofnef. Viruswasproduced in 293T cells
using Lipofectamine2000 (Invitrogen) as a transfection reagent; virus
was pseudotyped with Vesicular stomatitis virus protein G (VSV-G).
Virus was collected after 48 h, ﬁltered (0.45 μm), and viral capsid/p24
protein (CA p24) content was quantiﬁed by a Vironostika HIV-1 Ag kit
(bioMérieux).
HIV-1 infections
For single round infections, cells populations were infected with
VSV-G pseudotyped wt or Δvpu virus to 10% infection rates, as
determined by ﬂow cytometric detection of virus-derived eGFP
expression at 48 h p.i., in order to minimize superinfection events. For
studies of ongoing infection, cells were infected with 600 ng CA p24 per
106 cells by spinoculation (1500×g, at 37 °C for 2 h), followed by
incubation for 1 h at 37 °C, after which virus was removed by
centrifugation and cell washing.
Flow cytometry
Infection rates were determined by studying virus-derived eGFP
expression. Infection rates in single round infectionsweredetermined at
48 hp.i.; infection rates of ongoing infectionswasdetermined at72 hp.i.
Levels of cell surface tetherin in infected and uninfected cells were
assessed by ﬂow cytometry for PerCP (peridinin chlorophyll protein) at
72 h p.i. Staining for cell surface tetherinwas performed using a primary
rabbit anti-human-tetherin polyclonal antibody (1:3000) (NIH AIDS
Research and Reference Reagent Program (Miyagi et al., 2009)),
followed by a PerCP-labeled secondary goat anti-rabbit antibody
(1:250) (Santa Cruz Biotechnology). Cells were stained at 4 °C for
30 min and ﬁxed in 4% paraformaldehyde for 25 min. Uninfected and
infected cells were distinguished by virus-derived eGFP expression.
Flow cytometry analysis was performed on a minimum of 30,000 cells
using a FACSCalibur instrument (Becton Dickinson) and FlowJo 7.5
software (Tree Star).Virus release
Virus release into the supernatant was analyzed at 24, 48 and 72 h
p.i. using a quantitative reverse transcription-based assay (Oliveira et
al., 2009).
Statistical analysis
Data from at least three independent experiments were analyzed
utilizing GraphPad PRISM 5 software. Differences were analyzed for
statistical signiﬁcance using a one-way analysis of variance (ANOVA)
with Bonferroni's post-test for groups and Student's t-test for pairs of
data.
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